Form 4: LifeStance Health Director Acquires RSUs

LifeStance Health Group, Inc. reports that Director Sarah Personette acquired 17,746 restricted stock units on July 2, 2026.

Summary

• Sarah Personette, a Director at LifeStance Health Group, Inc., acquired 17,746 restricted stock units (RSUs) on July 2, 2026.
• These RSUs represent a contingent right to receive one share of the Issuer's common stock.
• Following this transaction, Personette beneficially owns 92,512 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard compensation-related stock grant rather than a discretionary purchase or sale by an insider.

Positives

• Director acquisition of stock units can signal confidence in the company's future prospects.
• The acquisition of 17,746 RSUs indicates a direct investment by a key insider.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, such as the acquisition of RSUs by a director, are common disclosures in the healthcare services sector and can provide insights into management's perception of company value.

Stakeholder Impact

• Shareholders: The acquisition of RSUs by a director may be viewed positively as a sign of insider confidence, though it is part of a standard compensation package.

Key Dates

Keywords

LifeStance Health, LFST, Form 4, Insider Transaction, Restricted Stock Units, RSUs, Beneficial Ownership, Director, Securities Exchange Act